BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10340047)

  • 1. A case of synchronous double primary lung cancer with neuroendocrine features.
    Niho S; Yokose T; Nagai K; Nishiwaki Y; Kodama T; Mukai K
    Jpn J Clin Oncol; 1999 Apr; 29(4):219-25. PubMed ID: 10340047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors.
    Iyoda A; Hiroshima K; Baba M; Saitoh Y; Ohwada H; Fujisawa T
    Ann Thorac Surg; 2002 Apr; 73(4):1049-54. PubMed ID: 11996239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis.
    Wiatrowska BA; Krol J; Zakowski MF
    Diagn Cytopathol; 2001 Jan; 24(1):58-64. PubMed ID: 11135471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined neoplasia of the lung: description of a case of adenocarcinoma mixed with typical carcinoid].
    Cavazza A; Toffanetti R; Ferrari G; Piana S; Putrino I; Gardini G
    Pathologica; 2001 Jun; 93(3):216-20. PubMed ID: 11433616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined large cell neuroendocrine carcinoma and spindle cell carcinoma of the lung.
    Khalifa M; Hruby G; Ehrlich L; Danjoux C; Perez-Ordoñez B
    Ann Diagn Pathol; 2001 Aug; 5(4):240-5. PubMed ID: 11510007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent expression of neuroendocrine markers in mucinous tubular and spindle cell carcinoma of the kidney.
    Kuroda N; Hes O; Miyazaki E; Shuin T; Enzan H
    Histol Histopathol; 2006 Jan; 21(1):7-10. PubMed ID: 16267782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of primary combined neuroendocrine carcinoma with squamous cell carcinoma in the upper gingiva.
    Mochizuki Y; Omura K; Sakamoto K; Nakanishi S; Satoh K; Marukawa E; Yamaguchi A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):e34-9. PubMed ID: 20303044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
    Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
    Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, pathologic and molecular characteristics of pulmonary high-grade neuroendocrine tumors].
    Danel C
    Ann Pathol; 2011 Nov; 31(5 Suppl):S76-8. PubMed ID: 22054468
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
    Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
    Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
    Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
    Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of cluster 1 small cell lung cancer antigen and chromogranin A in lung carcinomas.
    Noguchi M; Hirohashi S; Shimosato Y
    Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1315401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.